Misoprostol in patients taking non-steroidal anti-inflammatory drugs.
作者信息
Maiden N, Madhok R
出版信息
BMJ. 1995 Dec 9;311(7019):1518-9. doi: 10.1136/bmj.311.7019.1518.
Abstract
摘要
相似文献
1
Misoprostol in patients taking non-steroidal anti-inflammatory drugs.服用非甾体抗炎药患者使用米索前列醇的情况。
BMJ. 1995 Dec 9;311(7019):1518-9. doi: 10.1136/bmj.311.7019.1518.
2
Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration.
N Engl J Med. 1992 Nov 26;327(22):1575-80. doi: 10.1056/NEJM199211263272207.
3
Can gastroduodenal ulcers in NSAID users be prevented?非甾体抗炎药使用者的胃十二指肠溃疡能预防吗？
Ann Intern Med. 1993 Aug 15;119(4):337-9. doi: 10.7326/0003-4819-119-4-199308150-00015.
4
Protection of the gastric mucosa from NSAIDs.保护胃黏膜免受非甾体抗炎药的损害。
N Z Med J. 1992 Oct 28;105(944):436.
5
Prophylaxis at what cost? The debate continues.
Am J Gastroenterol. 1994 Aug;89(8):1264-6.
6
Prevention of peptic ulceration in patients receiving NSAIDs.
Br J Hosp Med. 1993;49(11):767-72.
7
Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
Clin Evid. 2004 Jun(11):1551-9.
8
[Individual prophylaxis against NSAID ulcers?].[针对非甾体抗炎药溃疡的个体预防措施？]
Fortschr Med. 1995 Apr 10;113(10):1.
9
Upper gastrointestinal complications related to non-steroidal anti-inflammatory drugs--what have we achieved so far?与非甾体抗炎药相关的上消化道并发症——我们目前取得了哪些进展？
Dig Liver Dis. 2004 Jan;36(1):1-3. doi: 10.1016/j.dld.2003.10.003.
10
[The efficacy of the synthetic prostaglandin Cytotec in preventing and treating symptomatic gastropathy].[合成前列腺素喜克溃在预防和治疗症状性胃病中的疗效]
Voen Med Zh. 1996 Feb;317(2):33-5.
引用本文的文献
1
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?提高非甾体抗炎药的成本效益处方是否有空间？
Pharmacoeconomics. 1996 Jun;9(6):484-96. doi: 10.2165/00019053-199609060-00003.
2
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. This reduction in risk is deemed worth while in other circumstances.服用非甾体抗炎药患者使用米索前列醇的情况。在其他情况下，这种风险降低被认为是值得的。
BMJ. 1996 Mar 30;312(7034):846-7. doi: 10.1136/bmj.312.7034.846b.
3
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. Analysis excluded in important events.服用非甾体抗炎药患者使用米索前列醇。分析排除重要事件。
BMJ. 1996 Mar 30;312(7034):846; author reply 847. doi: 10.1136/bmj.312.7034.846a.
本文引用的文献
1
Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.服用非甾体抗炎药的关节炎患者使用米索前列醇预防十二指肠溃疡和胃溃疡。米索前列醇研究组
Ann Intern Med. 1993 Aug 15;119(4):257-62. doi: 10.7326/0003-4819-119-4-199308150-00001.
2
A cost-utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs.
Arthritis Rheum. 1994 Mar;37(3):333-41. doi: 10.1002/art.1780370306.
3
4
The number needed to treat: a clinically useful measure of treatment effect.需治疗人数：一种临床实用的治疗效果衡量指标。
BMJ. 1995 Feb 18;310(6977):452-4. doi: 10.1136/bmj.310.6977.452.
5
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.米索前列醇可降低类风湿性关节炎患者接受非甾体抗炎药治疗时严重胃肠道并发症的发生率。一项随机、双盲、安慰剂对照试验。
Ann Intern Med. 1995 Aug 15;123(4):241-9. doi: 10.7326/0003-4819-123-4-199508150-00001.
6
Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.预防非甾体抗炎药所致胃十二指肠损伤：雷尼替丁对照试验
BMJ. 1988 Oct 22;297(6655):1017-21. doi: 10.1136/bmj.297.6655.1017.
7
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.饮食补充n-3多不饱和脂肪酸对单核细胞合成白细胞介素-1和肿瘤坏死因子的影响。
N Engl J Med. 1989 Feb 2;320(5):265-71. doi: 10.1056/NEJM198902023200501.
Zotero 插件